Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
ZBIO price, last 12 months
Key stats
- Previous close
- $26.42
- Open
- $26.63
- Day range
- $24.94 – $27.12
- 52-week range
- $13.50 – $44.60
- Volume
- 268.8K
- Avg volume (20 days)
- 490.7K
- Market cap
- $1.9B
Performance
Technicals and fundamentals
About Zenas BioPharma, Inc.
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.9B